Correlation Between Synlogic and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Synlogic and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synlogic and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Synlogic and Effector Therapeutics, you can compare the effects of market volatilities on Synlogic and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synlogic with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synlogic and Effector Therapeutics.
Diversification Opportunities for Synlogic and Effector Therapeutics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Synlogic and Effector is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Synlogic and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Synlogic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synlogic are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Synlogic i.e., Synlogic and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Synlogic and Effector Therapeutics
Given the investment horizon of 90 days Synlogic is expected to generate 0.34 times more return on investment than Effector Therapeutics. However, Synlogic is 2.95 times less risky than Effector Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 349.00 in Synlogic on August 29, 2024 and sell it today you would lose (209.00) from holding Synlogic or give up 59.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 51.2% |
| Values | Daily Returns |
Synlogic vs. Effector Therapeutics
Performance |
| Timeline |
| Synlogic |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Synlogic and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Synlogic and Effector Therapeutics
The main advantage of trading using opposite Synlogic and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synlogic position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.The idea behind Synlogic and Effector Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |